| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_020dff013107a2793a7dad3d7730a474 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B60J7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1995-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb091b0d965b0fb24f2264a4a523e87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6203dfa0757617fb41410ef97d27570
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b38a3f50a39d75dad78573d41686c50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f624c0ecae39aa5d16d8f75d7f26bb9 |
| publicationDate |
2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0680759-B1 |
| titleOfInvention |
Transdermal delivery of calcium channel blockers, such as nifedipine, nimodipine and nitrendipine |
| abstract |
A composition for transdermal delivery of a dihydropyridine-type calcium antagonist such as nifedipine, nimodipine or nitrendipine comprises 1 to 20 weight % of the calcium antagonist in a mixed liquid comprising 0.1 to 50 mole % cis-oleic acid and 0.1 to 97 mole % dimethylisosorbide dispersed in a propylene glycol base. |
| priorityDate |
1994-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |